跳至主要内容
临床试验/NCT03414827
NCT03414827招募中不适用

Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma

Zealand University Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
DNA

研究概览

简要总结

Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who have been diagnosed with kidney cancer.

排除标准

  • Patients without signs of malignancy at final histology report.
  • Incapacitated patients.

结局指标

主要结局

DNA

时间窗: 30 days

Sequence variation in specific genes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nessn Azawi

Clinical Professor

Zealand University Hospital

研究点 (1)

Loading locations...

相似试验